偶发性结核性附睾炎/附睾睾丸炎:台湾一家三级中心的回顾性分析
回顾2000至2019年因初步诊断为慢性附睾炎/附睾睾丸炎或附睾/睾丸肿瘤而手术的25例患者,术后病理均偶发诊断为结核性附睾炎(48.0%)或附睾睾丸炎(52.0%)。主要临床表现为可触及阴囊肿块(76.0%);术后完成化疗的19例中15例(78.9%)完全康复,4例(21.1%)预后不良;3例未化疗者中1例结核复发、1例 later 发生膀胱癌。结论认为该病诊断困难,完全抗结核化疗为必需,建议终身随访。
要点
- 因慢性附睾炎/附睾睾丸炎或肿瘤手术的25例患者术后病理均偶发诊断为结核性附睾炎/附睾睾丸炎。
- 可触及阴囊肿块为最主要表现(76.0%),老年、生殖器外结核史、抗生素反应差及阴囊皮肤病变可为线索。
- 术后完成化疗19例中15例(78.9%)完全康复,未化疗3例中1例结核复发、1例 later 发生膀胱癌。
核心结论
- 结核性附睾炎/附睾睾丸炎诊断困难,但老年患者、生殖器外结核病史、抗生素治疗反应差及阴囊皮肤病变等临床线索可辅助诊断。
- 即使结核病灶已完全切除,也必需完成抗结核化疗;化疗后症状未缓解时可考虑补充手术干预;因复发率较高,建议终身随访。
研究设计与样本
- 回顾性分析2000至2019年在台湾一家三级中心因初步诊断为慢性附睾炎/附睾睾丸炎或附睾/睾丸肿瘤而接受手术的患者,共25例,平均年龄60.6岁。
主要发现
- 25例均根据手术组织病理学检查偶发诊断为结核性附睾炎(48.0%)和结核性附睾睾丸炎(52.0%)。
- 可触及阴囊肿块是主要表现(76.0%)。
- 术后完成化疗的19例患者中,15例(78.9%)完全康复,4例(21.1%)预后不良,其中3例发生结核性自主肾切除、1例在完成化疗数年后需再次手术。
- 术后未接受化疗的3例(12.0%)患者中,1例出现脊柱和肺部结核复发,1例 later 发生膀胱癌。
临床怎么用
- 作者认为,即使结核病灶已完全切除,也必需完成抗结核化疗。
- 作者认为,化疗后症状未缓解时可考虑补充手术干预。
- 作者建议因复发率较高应进行终身随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the earliest noticeable manifestation and diagnosis in patients diagnosed with tuberculosis (TB) epididymitis/epididymo-orchitis incidentally and to analyze their responses to surgical and medical treatment. METHODS: Patients who underwent surgery for the preliminary impression of chronic epididymitis/epididymo-orchitis or epididymal/testicular tumor from 2000 to 2019 were included in the study. The clinical presentations, laboratory data, radiological examinations, and operative findings were analyzed retrospectively. The outcomes were assessed by the responses to anti-TB chemotherapy and post treatment radiographic evaluations. RESULTS: All of our 25 patients with a mean age of 60.6 years were diagnosed incidentally with TB epididymitis (48.0%) and TB epididymo-orchitis (52.0%) according to the histopathological findings from their surgeries. The presence of a palpable scrotal mass (76.0%), was the major presentation. Nineteen (76.0%) patients had undergone complete chemotherapy after the surgery and 15 (78.9%) patients showed complete recovery. Four (21.1%) patients had unfavorable outcomes, 3 had TB autonephrectomies and 1 required re-surgery years after complete chemotherapy. Of the 3 (12.0%) patients who did not receive chemotherapy after their surgeries, 1 had a TB relapse in the spine and lung and 1 developed bladder cancer years later. CONCLUSION: Tuberculosis epididymitis/epididymo-orchitis is difficult to diagnose. However, some clinical clues can assist including aged patients, extragenital TB histories, poor responses to antibiotic treatment and scrotal skin lesion. Complete anti-TB chemotherapy is mandatory even after the total removal of TB lesion. Supplemental surgical interventions can be considered when the symptoms are not relieved after chemotherapy. Lifespan follow-up is recommended due to high relapse rate.
引用
- Yang YK, Chen HW, Weng LC, et al. Incidental Tuberculosis Epididymitis/Epididymo-orchitis: A Retrospective Analysis at a Tertiary Center in Taiwan. Urology. 2022. PMID: 35798186. doi:10.1016/j.urology.2022.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。